DALLAS, Dec. 12, 2016 -- CSW Industrials, Inc. (the “Company”) (NASDAQ:CSWI), a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments: Industrial Products; Coatings, Sealants & Adhesives; and Specialty Chemicals, today announced that its Board of Directors has elected J. Kent Sweezey as a member of the Board. With the addition of Mr. Sweezey, the Company’s Board increases to six members, five of whom are independent. He will initially serve on the Board’s Audit, Compensation and Talent Development, and Nominating and Corporate Governance committees.
Mr. Sweezey, 64, is a founding partner of Turnbridge Capital, LLC, an energy services, equipment and infrastructure-focused private equity firm, which was founded in 2008. He currently serves as a member of the boards of directors of Impact Selector, Inc. and DeBusk Services Group. Prior to co-founding Turnbridge Capital, Mr. Sweezey served as the Managing Partner of Centre Southwest Partners, LLC, a middle-market private equity firm focused primarily on energy services and equipment-related investments. Prior to his time with Centre Southwest Partners, Mr. Sweezey was with Donaldson, Lufkin & Jenrette (DLJ) and its successor firm, Credit Suisse First Boston, from 1984 to 2002, serving most recently as a managing director, where he focused on transactions for companies in the energy sector, as well as companies in the consumer products, building products, and manufacturing sectors. Mr. Sweezey was also involved in DLJ's early principal investing activities through its investments in Seven-Up Company, Dr. Pepper/Seven-Up Companies, and Dr. Pepper Bottling Company of Texas, where he served on the board of directors from 1989 to 1999.
Robert M. Swartz, lead independent director of the Company’s Board of Directors and Chairman of its Nominating and Corporate Governance Committee, commented, “Earlier this year, we announced our intention to expand our board of directors with the addition of directors who possess the requisite skills and experience to assist in executing our strategic growth and capital allocation plans. Kent’s appointment is our first step in this process, bringing to the Company’s Board significant strategic acquisition and financial expertise, in addition to executive leadership and board of directors experience.”
Joseph B. Armes, the Company’s Chairman and CEO, commented, “Kent’s background and expertise aligns well with the Company’s vision and makes him an ideal fit to support the further development and execution of our growth strategy to drive long term stockholder value. Consistent with our previously-announced plans, the Board continues its search process to identify a seventh well-qualified director, which we expect to announce in the first quarter of calendar 2017.”
Mr. Sweezey received a Bachelor of Arts degree from Duke University, a Juris Doctorate degree from Southern Methodist University and a Master's of Business Administration degree from the Darden School at the University of Virginia.
About CSW Industrials
CSWI is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments: Industrial Products; Coatings, Sealants & Adhesives; and Specialty Chemicals. CSWI’s broad portfolio of leading products provides performance optimizing solutions to its customers. CSWI’s products include mechanical products for heating, ventilation and air conditioning (“HVAC”) and refrigeration applications, coatings and sealants and high performance specialty lubricants. Markets that CSWI serves include HVAC, general industrial markets, rail car and locomotive, plumbing, commercial construction, oil and gas, mining, electrical, steel and transportation.
Investor Contact: Michael Callahan ICR, Inc. [email protected] | 203-682-8311 Media Contacts: Phil Denning or Jason Chudoba ICR, Inc. [email protected] | 646-277-1258, [email protected] | 646-277-1249


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
First Western Ship Transits Strait of Hormuz Since Iran War Began
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 



